Q3 2025 Cardinal Health Inc Earnings Call Transcript
Key Points
- Cardinal Health Inc (CAH) reported strong third-quarter results with a 21% increase in operating earnings and a 13% rise in EPS.
- The company raised its fiscal '25 EPS guidance to a range of $8.05 to $8.15, reflecting confidence in sustainable long-term growth.
- Significant growth was observed in the Pharmaceutical and Specialty Solutions segment, driven by strong utilization trends and execution.
- The acquisition of GI Alliance and Integrated Oncology Network is performing well, contributing positively to the company's results.
- Cardinal Health Inc (CAH) completed the acquisition of Advanced Diabetes Supply Group, which is expected to be accretive to EPS immediately.
- The company faces potential tariff impacts, with an estimated $200 million to $300 million in gross tariff costs anticipated in fiscal '26.
- Despite mitigation efforts, the GMPD segment continues to face challenges, with guidance narrowed to the lower end of the prior range.
- Interest and other expenses increased by $38 million due to acquisition-related financing costs.
- The effective tax rate increased by 2.5 percentage points from the prior year, impacting net results.
- The company is navigating a complex macro environment, which could pose risks to future performance.
Hello, and welcome to the third-quarter fiscal year 2025 Cardinal Health Incorporated earnings conference call. My name is George, and I'll be your coordinator for today's event. Please note, this conference is being recorded. (Operator Instructions)
I'd like to now turn the call over to your host today, Mr. Matt Sims, Vice President, Investor Relations, to begin today's conference. Thank you.
Welcome to this morning's Cardinal Health third-quarter fiscal '25 earnings conference call, and thank you for joining us. With me today are Cardinal Health's CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning's earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
